Literature DB >> 29891611

Identification of 14-α-Lanosterol Demethylase (CYP51) in Scedosporium Species.

Anne Bernhardt1, Wieland Meyer2,3, Volker Rickerts1, Toni Aebischer4, Kathrin Tintelnot1.   

Abstract

Scedosporium spp. cause infections (scedosporiosis) in both immunocompetent and immunocompromised individuals and may persistently colonize the respiratory tract in patients with cystic fibrosis (CF). They are less susceptible against azoles than are other molds, such as Aspergillus spp., suggesting the presence of resistance mechanisms. It can be hypothesized that the decreased susceptibility of Scedosporium spp. to azoles is also CYP51 dependent. Analysis of the Scedosporium apiospermum and Scedosporiumaurantiacum genomes revealed one CYP51 gene encoding the 14-α-lanosterol demethylase. This gene from 159 clinical or environmental Scedosporium isolates and three Lomentospora prolificans isolates has been sequenced and analyzed. The Scedosporium CYP51 protein clustered with the group of known CYP51B orthologues and showed species-specific polymorphisms. A tandem repeat in the 5' upstream region of Scedosporium CYP51 like that in Aspergillus fumigatus could not be detected. Species-specific amino acid alterations in CYP51 of Scedosporium boydii, Scedosporiumellipsoideum, Scedosporium dehoogii, and Scedosporiumminutisporum isolates were located at positions that have not been described as having an impact on azole susceptibility. In contrast, two of the three Sapiospermum-specific amino acid changes (Y136F and G464S) corresponded to respective mutations in A. fumigatus CYP51A at amino acid positions 121 and 448 (Y121F and G448S, respectively) that had been linked to azole resistance.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Cyp51; antifungal agents; azole resistance

Mesh:

Substances:

Year:  2018        PMID: 29891611      PMCID: PMC6105797          DOI: 10.1128/AAC.02599-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

Review 1.  Many facets of mammalian lanosterol 14alpha-demethylase from the evolutionarily conserved cytochrome P450 family CYP51.

Authors:  Natasa Debeljak; Martina Fink; Damjana Rozman
Journal:  Arch Biochem Biophys       Date:  2003-01-01       Impact factor: 4.013

Review 2.  Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease--a diagnostic and therapeutic challenge.

Authors:  Ina Tammer; Kathrin Tintelnot; Rüdiger C Braun-Dullaeus; Christian Mawrin; Cordula Scherlach; Dirk Schlüter; Wolfgang König
Journal:  Int J Infect Dis       Date:  2011-04-20       Impact factor: 3.623

Review 3.  Antifungal therapy in invasive fungal infections.

Authors:  Sharon C-A Chen; E Geoffrey Playford; Tania C Sorrell
Journal:  Curr Opin Pharmacol       Date:  2010-07-02       Impact factor: 5.547

Review 4.  Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist.

Authors:  Josep Guarro; A Serda Kantarcioglu; Regine Horré; Juan Luis Rodriguez-Tudela; Manuel Cuenca Estrella; Juan Berenguer; G Sybren de Hoog
Journal:  Med Mycol       Date:  2006-06       Impact factor: 4.076

5.  A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B.

Authors:  Javier Capilla; Emilio Mayayo; Carolina Serena; F Javier Pastor; Josep Guarro
Journal:  J Antimicrob Chemother       Date:  2004-10-27       Impact factor: 5.790

6.  The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.

Authors:  Marcin G Fraczek; Michael Bromley; Ahmed Buied; Caroline B Moore; Ranjith Rajendran; Riina Rautemaa; Gordon Ramage; David W Denning; Paul Bowyer
Journal:  J Antimicrob Chemother       Date:  2013-04-10       Impact factor: 5.790

7.  Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.

Authors:  Jingsi Zeng; Katsuhiko Kamei; Yuecheng Zheng; Kazuko Nishimura
Journal:  Nihon Ishinkin Gakkai Zasshi       Date:  2004

8.  Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus.

Authors:  J E Parker; M Merkamm; N J Manning; D Pompon; S L Kelly; D E Kelly
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

9.  Draft Genome Sequence of the Pathogenic Fungus Scedosporium apiospermum.

Authors:  Patrick Vandeputte; Sarah Ghamrawi; Mathias Rechenmann; Agnès Iltis; Sandrine Giraud; Maxime Fleury; Christopher Thornton; Laurence Delhaès; Wieland Meyer; Nicolas Papon; Jean-Philippe Bouchara
Journal:  Genome Announc       Date:  2014-10-02

10.  Draft Genome of Australian Environmental Strain WM 09.24 of the Opportunistic Human Pathogen Scedosporium aurantiacum.

Authors:  Åsa Pérez-Bercoff; Alexie Papanicolaou; Marc Ramsperger; Jashanpreet Kaur; Hardip R Patel; Azian Harun; Shu Yao Duan; Liam Elbourne; Jean-Philippe Bouchara; Ian T Paulsen; Helena Nevalainen; Wieland Meyer; Gavin A Huttley
Journal:  Genome Announc       Date:  2015-02-12
View more
  3 in total

1.  Antifungal Susceptibility Profiles and Drug Resistance Mechanisms of Clinical Lomentospora prolificans Isolates.

Authors:  Yongqin Wu; Nina Grossman; Marissa Totten; Warda Memon; Anna Fitzgerald; Chunmei Ying; Sean X Zhang
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 2.  The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors.

Authors:  Jingxiang Zhang; Liping Li; Quanzhen Lv; Lan Yan; Yan Wang; Yuanying Jiang
Journal:  Front Microbiol       Date:  2019-04-24       Impact factor: 5.640

Review 3.  Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens.

Authors:  Katharina Rosam; Brian C Monk; Michaela Lackner
Journal:  J Fungi (Basel)       Date:  2020-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.